139 related articles for article (PubMed ID: 35063764)
21. Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.
Shen J; Xie M; Xu Y; Qian Q; Qiu T; Shi W; Ren D; Ji J; Huang J
Biochem Biophys Res Commun; 2023 Jan; 638():184-191. PubMed ID: 36462492
[TBL] [Abstract][Full Text] [Related]
22. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
23. Downregulated Long Noncoding RNA GAS5 Fails to Function as Decoy of CEBPB, Resulting in Increased GDF15 Expression and Rapid Ovarian Cancer Cell Proliferation.
Guo LL; Wang SF
Cancer Biother Radiopharm; 2019 Oct; 34(8):537-546. PubMed ID: 31314588
[No Abstract] [Full Text] [Related]
24. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules.
Zhang XQ; Ding YW; Chen JJ; Xiao X; Zhang W; Zhou L; Kong QW; Shi MZ; Yang J; Jiang B; Guo C; Han YL
J Ethnopharmacol; 2020 Oct; 261():113067. PubMed ID: 32505840
[TBL] [Abstract][Full Text] [Related]
25. LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression.
Qiao ZW; Jiang Y; Wang L; Wang L; Jiang J; Zhang JR; Mu P
BMC Cancer; 2021 Sep; 21(1):1004. PubMed ID: 34496800
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target.
Shahidul Makki M; Cristy Ruteshouser E; Huff V
Exp Cell Res; 2013 Mar; 319(5):612-22. PubMed ID: 23291318
[TBL] [Abstract][Full Text] [Related]
28. USP18-mediated protein deISGylation and its role in tuberculosis and other infectious diseases.
Qi'ao Z; Zi-Lu W; Pei-Bo L; Jian-Ping X
Yi Chuan; 2023 Nov; 45(11):998-1006. PubMed ID: 38764265
[TBL] [Abstract][Full Text] [Related]
29. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance.
Ketscher L; Hannß R; Morales DJ; Basters A; Guerra S; Goldmann T; Hausmann A; Prinz M; Naumann R; Pekosz A; Utermöhlen O; Lenschow DJ; Knobeloch KP
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1577-82. PubMed ID: 25605921
[TBL] [Abstract][Full Text] [Related]
30. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
[TBL] [Abstract][Full Text] [Related]
31. USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA.
Zhang M; Zhang MX; Zhang Q; Zhu GF; Yuan L; Zhang DE; Zhu Q; Yao J; Shu HB; Zhong B
Cell Res; 2016 Dec; 26(12):1302-1319. PubMed ID: 27801882
[TBL] [Abstract][Full Text] [Related]
32. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
[TBL] [Abstract][Full Text] [Related]
33. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
34. Long Intergenic Noncoding RNA
Takeiwa T; Mitobe Y; Ikeda K; Hasegawa K; Horie K; Inoue S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681900
[TBL] [Abstract][Full Text] [Related]
35. Adipose-derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein.
Chu Y; Zhu C; Wang Q; Liu M; Wan W; Zhou J; Han R; Yang J; Luo W; Liu C; Zhou H; Li M; Yu F; Ye Y
J Cell Mol Med; 2021 May; 25(9):4434-4443. PubMed ID: 33830648
[TBL] [Abstract][Full Text] [Related]
36. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
37. FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development.
Ji J; Shen J; Xu Y; Xie M; Qian Q; Qiu T; Shi W; Ren D; Ma J; Liu W; Liu B
Cell Death Dis; 2022 May; 13(5):442. PubMed ID: 35525855
[TBL] [Abstract][Full Text] [Related]
38. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
[No Abstract] [Full Text] [Related]
39. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
40. USP18 is an essential regulator of muscle cell differentiation and maturation.
Olie CS; Pinto-Fernández A; Damianou A; Vendrell I; Mei H; den Hamer B; van der Wal E; de Greef JC; Raz V; Kessler BM
Cell Death Dis; 2023 Mar; 14(3):231. PubMed ID: 37002195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
